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277 Nutritional status of Russian children with cystic ﬁbrosis
diagnosed before and after neonatal screening
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Objectives: The mandatory cystic ﬁbrosis (CF) neonatal screening was introduced
in Russia everywhere since 2006. The aim of the study was to elucidate whether
early diagnosis of CF by neonatal screening had a positive inﬂuence on the
nutritional status of CF children.
Methods: Weight and height of 112 CF children (216 measurements in all) under
6 years of age were recorded according to standard methods and expressed as
standard deviation scores (z-score) and percentiles adjusted for age and gender
using WHOAnthro- and WHOAnthroPlus programs. 45 children (93 measurements)
diagnosed by symptoms formed group I and 67 children (123 measurements) born
between 2006–2012 and diagnosed by neonatal screening formed group II.
Results: The mean body mass index (BMI) was higher in II group (14.89±1.86 [I]
and 15.56±1.64 [II] p = 0.001). The mean weight for height (37.2/49.8, p = 0.016),
weight for age (29.9/38.9, p = 0.017) and BMI (34.6/45.8, p = 0.017) percentiles
were also slightly higher in group II. Height for age percentile (31.6/37.9) did not
differ between groups. However, the part of stunted (height for age z-score <−2;
6.5/7.7%), underweight (weight for age <−2; 9.7/22.8%), and wasted (weight for
height z-score <−2; 4.6/20.9%) was higher in group II, the same as low (<−2) BMI
z-score (8.6/13.8%).
Conclusion: Certain improvement of nutritional status mean indexes can be ob-
served in children diagnosed by neonatal screening. We suppose that the higher
portion of patients with low z-scores in after-screening group II is a result of early
diagnose but inadequate treatment in some distant Russian regions.
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Objectives: To assess the nutrition status among children with CF using conven-
tional, as well as novel nutrition assessment tools. To compare conventional and
novel nutrition assessment tools.
Methods: Nutrition status of 64 children with CF (56.25% males, mean age
10.2 years, range 0.1−18 years) was evaluated. Anthropometry was expressed as
z-scores for age and sex using WHO Anthro software and classiﬁed following
the WHO criteria. The proportion of patients below the “BMI p goal” (BMI p-50th)
was also evaluated. Phase angle (PhA) and body cell mass (BCM) were assessed by
BIA. Three-day food intake was recorded and was analyzed using “Food Processor”.
Overall diet quality was assessed using the Diet Quality Index International (DQI-I).
The malnutrition risk was also evaluated by the “SMART score” software (SSc).
Results: Seven out of the 64 patients (10.9%) were malnourished (Weight for Age
z-score <−2). Thirty-one out of 64 patients (48.4%) did not fulﬁll the BMIp-50th
goal. Intake/Requirements Ratio (median) was 77.9% for energy and 63.5% for
protein. The mean PhA values were 4.84±0.95. PhA values were signiﬁcantly
correlated with body mass index (BMI) (P = 0.027), BMC (p = 0.047), energy intake
(p = 0.049) and age of diagnosis (p = 0.002). Statistically signiﬁcant correlation was
found between Smart Score and energy intake (p = 0.015), protein intake (p = 0.034),
as well as weight for age z-score (p = 0.001) and height for age z-score (p = 0.003).
Conclusions: Novel nutrition assessment tools (PhA and smart score values)
correlate with traditional nutrition assessment tools, indicating the nutritional status
of children and adolescents with CF.
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Objectives: To evaluate the composition of fatty acids (FA) in erythrocytes and its
correlation with the nutritional status, genotype, pancreatic and pulmonary function
in cystic ﬁbrosis (CF) patients.
Methods: Observational cross-sectional study in CF children and adolescents
clinically stable, attending in Brazil reference center. We analyzed the FA in
erythrocytes phospholipids by gas chromatography. The energy and FA intake were
obtained by three 24-hour recalls. The anthropometric indicators (BMI and height-
for-age) were based in CF Consensus recommends. Pancreatic insufﬁciency was
classiﬁed by fecal elastase-1 and fecal fat excretion. Lung function impairment was
based on the %FEV1 predicted. The genotyping was done by polymerase chain
reaction. The Pearson correlation, ANOVA and t-test were used by SPSS 17.0 with
5% signiﬁcance.
Results: We observed in erythrocytes of 27 patients (138.8±42 months) low
concentrations of palmitoleic acid, oleic acid, linoleic acid (LA) and docosaexaenoic
acid (DHA) and high concentrations of arachidonic acid (AA), dihomo-g-linoleic
acid, AA: DHA and palmitoleic:LA ratio. Correlations were found between the
intake of DHA and LA: DHA ratio (r = 0.738 p = 0.000) and AA: DHA ratio
(r = 0.629 p = 0.001) in erythrocytes, and EPA intake with ALA concentration
(r = 0.576 p = 0.003). The height-for-age was related with AA:DHA ratio in cells
(p = 0.035). In DF508 homozygous patients AA concentrations in erythrocytes were
greater compared to heterozygous (p = 0.038).
Conclusion: Imbalance and deﬁciency of FA were observed in erythrocytes of
CF pediatric patients and related to ingestion of FA, height-for-age and DF508
homozygous mutation.
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Objectives: To investigate the effects of n-3 fatty acids supplementation on
inﬂammatory markers in cystic ﬁbrosis (CF) children and adolescents.
Methods: A prospective clinical trial, before-after study, held in Brazil CF reference
center. Patients with clinically stable conditions, between 5 and 20 years, were
supplemented with ﬁsh oil capsules (180mg of EPA − Eicosapentaenoic acid and
120mg of DHA − Docosahexaenoic acid/1g), during 3 months (20 to 30mg/kg/day).
Seric tumor necrosis factor (TNF-a) and interleukins (IL-1, IL-6 and IL-8) were
analyzed by ELISA and C-reactive protein (CRP) by Nephelometry. The genotyping
was done by polymerase chain reaction. Patients were divided into smaller (children
group-CG) and larger than 10 years (adolescents group-AG). Comparisons were
performed using Wilcoxon and Mc Nemar test, with 5% signiﬁcance, by SPSS
software version 17.0.
Results: 57 patients were studied (CG= 26, AG= 31). In CG 19.2% were DF508
homozygous and 53.8% heterozygous and in AG 9.7% and 45.2% respectively.
Reduction of TNF-a seric concentrations were observed in both groups after
supplementation (p< 0.05). The concentrations of seric IL-1 b had a tendency to
increase and IL-6 were signiﬁcantly increased in CG. Seric IL-8 concentration was
not modiﬁed. CRP levels (>0.5mg/ml) that indicates patient inﬂammation were
reduced in 57.8% (CG) and 15.5% (AG) after supplementation (p< 0.05).
Conclusion: n-3 fatty acids supplementation reduced seric concentration of TNF-
a and the percentage of patients undergoing inﬂammation, should be considered
during treatment of CF pediatric patients, especially with DF508 mutation.
